New pathological progress of lung adenocarcinoma in pulmonary nodular lesions
10.3760/cma.j.cn101721-20231109-00135
- VernacularTitle:肺结节性病变-肺腺癌病理新进展
- Author:
Weiqiang YI
1
;
Yigen WU
;
Xue YI
Author Information
1. 厦门医学院附属第二医院胸心外科 厦门医学院呼吸疾病研究所，厦门 361021
- Keywords:
Pulmonary nodular lesions;
Malignant pulmonary nodule;
Lung adenocarcinoma;
Pathological classification;
Prognosis;
Surgical operation
- From:
Clinical Medicine of China
2024;40(1):36-40
- CountryChina
- Language:Chinese
-
Abstract:
Pulmonary nodular lesions include benign and malignant pulmonary nodules. Lung adenocarcinoma is the most common type of malignant pulmonary nodules. Lung adenocarcinoma includes precursor gland lesions minimally invasive adenocarcinoma, invasive mucinous adenocarcinoma and invasive non mucinous adenocarcinoma. The surgical methods and prognosis vary depending on the pathological subtypes. At present, it is proposed that the proportion of micropapillary, solid components in tumor alveolar dissemination and subtypes directly affect surgical methods and prognosis. Therefore, this article proposes that wedge lung resection can be performed for precursor glandular lesions. Subpulmonary lobectomy can be performed for minimally invasive adenocarcinoma. Invasive adenocarcinoma requires lobectomy and lymph node dissection. Even if patients with stage Ia lung adenocarcinoma who contain solid components in tumor alveolar dissemination , micropapillary, and pleural invasion components are recommended for postoperative adjuvant treatment.
